# Genotype and Age at Onset Drive Vermis Atrophy in CACNA1A- and GAA-FGF14-related Ataxias

**Authors:** Elisabetta Indelicato, Wolfgang Nachbauer, Matthias Amprosi, David Pellerin, Stephanie Mangesius, Elke R. Gizewski, Stefan Kiechl, Bernhard Brais, Sylvia Boesch, Florian Krismer

PMC · DOI: 10.1007/s12311-026-01966-8 · Cerebellum (London, England) · 2026-03-04

## TL;DR

This study shows that genetic factors and age at which symptoms begin strongly influence the degree of cerebellar vermis atrophy in two types of inherited ataxia.

## Contribution

The study identifies genotype-specific and age-related patterns of vermian atrophy in CACNA1A and GAA-FGF14-related ataxias using deep learning-based MRI analysis.

## Key findings

- Vermian atrophy is most prominent in patients with missense CACNA1A variants and early disease onset.
- Age at onset correlates with vermian atrophy (rs(26) = 0.47, p = 0.01), but not with clinical severity of chronic ataxia.
- Three distinct atrophy patterns were identified, with genotype and episodic symptom type differing across clusters.

## Abstract

CACNA1A- and GAA-FGF14-related channelopathies are among the most frequent genetic etiologies of cerebellar ataxia. They display overlapping features consisting of both chronic and episodic neurological symptoms and usually show only a mild cerebellar atrophy in imaging studies, with prevalent involvement of the vermis. To evaluate cerebellar volumetry as a biomarker for distinguishing between these disorders and for understanding their neuroanatomical correlates. We applied a deep learning method (CerebNet) for the lobular segmentation and volumetry assessment of the cerebellum on 3.0 Tesla MRI scans of patients with genetically confirmed CACNA1A- (n = 16) and GAA-FGF14-related (n = 12) ataxia. K-means clustering and principal component analysis were employed to assess infratentorial atrophy patterns. Three distinct clusters based on the patterns of infratentorial volume loss were established, with vermian atrophy contributing the most. The degree of vermian atrophy was not correlated with the clinical severity of chronic ataxia, but with age at disease onset (rs(26) = 0.47, p = 0.01). The cluster with most marked atrophy of the vermis comprised patients with missense CACNA1A variants who exhibited an early disease onset and migraine with aura as episodic manifestation. Conversely, there was an increase in the frequency of episodic ataxia and both loss-of-function CACNA1A variants and GAA-FGF14-expansions as genotypes when progressing from clusters with more to less severe vermian atrophy. Age at onset and the modality of channel dysfunction are key determinants of cerebellar volume loss in CACNA1A and GAA-FGF14-disease.

The online version contains supplementary material available at 10.1007/s12311-026-01966-8.

## Linked entities

- **Genes:** CACNA1A (calcium voltage-gated channel subunit alpha1 A) [NCBI Gene 773], FGF14 (fibroblast growth factor 14) [NCBI Gene 2259], GAA (alpha glucosidase) [NCBI Gene 2548]
- **Diseases:** ataxia (MONDO:0000437), migraine with aura (MONDO:0005475)

## Full-text entities

- **Genes:** GAA (alpha glucosidase) [NCBI Gene 2548] {aka IOPD, LOPD, LYAG}, CACNA1A (calcium voltage-gated channel subunit alpha1 A) [NCBI Gene 773] {aka APCA, BI, CACNL1A4, CAV2.1, DEE42, EA2}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, FGF14 (fibroblast growth factor 14) [NCBI Gene 2259] {aka FGF-14, FHF-4, FHF4, NYS4, SCA27, SCA27A}
- **Diseases:** Parkinson (MESH:D010302), Migraine with aura (MESH:D020325), Ion channel dysfunction (MESH:D020513), Movement Disorders (MESH:D009069), cognitive impairment (MESH:D003072), migraine (MESH:D008881), Ataxic syndromes (MESH:D001039), Ataxia (MESH:D001259), cerebellar ataxia (MESH:D002524), spinocerebellar ataxia 27B (MESH:D020754), Vermis Atrophy (MESH:C536293), inherited ataxias (MESH:D013132), channel (MESH:C538353), Cerebellar atrophy (MESH:D002526), GAA-FGF14-disease (MESH:D006009), Familial Hemiplegic Migraine 1 (MESH:C536890), atrophy of the cerebellar vermis (MESH:C537206), volume loss (MESH:D016388), Episodic Ataxia Type 2 (MESH:C535506), CACNA1A disease (MESH:D004194), neurodegeneration (MESH:D019636), atrophy (MESH:D001284), channelopathies (MESH:D053447), episodic ataxia (MESH:C580065), developmental encephalopathies (MESH:C567924), brain atrophy (MESH:C566985), MCI (MESH:D060825), AD (MESH:D000544)
- **Chemicals:** Ca2+ (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956909/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12956909/full.md

---
Source: https://tomesphere.com/paper/PMC12956909